Search Results - "De Backer, L."

Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study by Grymonprez, Maxim, De Backer, Tine L, Bertels, Xander, Steurbaut, Stephane, Lahousse, Lies

“…Although non-vitamin K antagonist oral anticoagulants (NOACs) are recommended over vitamin K antagonists (VKAs) in atrial fibrillation (AF) management, direct…”
Get full text

Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis by Grymonprez, Maxim, Steurbaut, Stephane, De Backer, Tine L, Petrovic, Mirko, Lahousse, Lies

“…Atrial fibrillation (AF), the most common cardiac arrhythmia, typically increases with age. Oral anticoagulants (OACs) are the cornerstone of treatment to…”
Get full text

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study by Grymonprez, Maxim, Capiau, Andreas, Steurbaut, Stephane, Mehuys, Els, Boussery, Koen, De Backer, Tine L., Lahousse, Lies

“…Background Since non-vitamin K antagonist oral anticoagulants (NOACs) do not require coagulation monitoring, concerns of lower adherence and persistence to…”
Get full text

Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants: A nationwide cohort study by Grymonprez, Maxim, Petrovic, Mirko, De Backer, Tine L., Steurbaut, Stephane, Lahousse, Lies

“…Data on non-vitamin K antagonist oral anticoagulant (NOAC) use in patients with atrial fibrillation (AF) and a history of falls are limited. Therefore, we…”
Get full text

The effects of long-term noninvasive ventilation in hypercapnic COPD patients: a randomized controlled pilot study by De Backer, L, Vos, W, Dieriks, B, Daems, D, Verhulst, S, Vinchurkar, S, Ides, K, De Backer, J, Germonpre, P, De Backer, W

“…Noninvasive ventilation (NIV) is a well-established treatment for acute-on- chronic respiratory failure in hypercapnic COPD patients. Less is known about the…”
Get full text

The sEROtonergic pathway: a hERO for the brain, a zERO for the valves? by De Backer, Tine L M, Timmermans, Frank

Get more information

Functional imaging using computer methods to compare the effect of salbutamol and ipratropium bromide in patient-specific airway models of COPD by De Backer, L A, Vos, W G, Salgado, R, De Backer, J W, Devolder, A, Verhulst, S L, Claes, R, Germonpré, P R, De Backer, W A

“…Salbutamol and ipratropium bromide improve lung function in patients with chronic obstructive pulmonary disease (COPD). However, their bronchodilating effect…”
Get full text

Naftidrofuryl for intermittent claudication by de Backer, Tine L M, Vander Stichele, Robert, Lehert, Philippe, Van Bortel, Luc

“…Lifestyle changes and cardiovascular prevention measures are a primary treatment for intermittent claudication (IC). Symptomatic treatment with vasoactive…”
Get more information

Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis by Grymonprez, Maxim, Simoens, Cynthia, Steurbaut, Stephane, De Backer, Tine L, Lahousse, Lies

“…Non-vitamin K antagonist oral anticoagulants (NOACs) are effective and safe alternatives compared with vitamin K antagonists (VKAs) for thromboembolic…”
Get full text

Carotid to femoral pulse wave velocity: a comparison of real travelled aortic path lengths determined by MRI and superficial measurements by Huybrechts, Sofie A.M, Devos, Daniel G, Vermeersch, Sebastian J, Mahieu, Dries, Achten, Eric, de Backer, Tine L.M, Segers, Patrick, van Bortel, Luc M

“…OBJECTIVESCarotid–femoral pulse wave velocity (PWV) is the gold standard method for determination of arterial stiffness. PWV is assessed by dividing travelled…”
Get full text

Buflomedil for intermittent claudication by de Backer, Tine L M, Vander Stichele, Robert

“…Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during exercise and is relieved with rest…”
Get more information

Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation and (Morbid) Obesity or Low Body Weight: a Systematic Review and Meta-Analysis by Grymonprez, Maxim, De Backer, Tine L., Steurbaut, Stephane, Boussery, Koen, Lahousse, Lies

“…Purpose Oral anticoagulants are crucial for preventing systemic thromboembolism in atrial fibrillation (AF), with guidelines preferring non-vitamin K…”
Get full text

Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysis by Grymonprez, Maxim, Vanspranghe, Kevin, Steurbaut, Stephane, De Backer, Tine L., Lahousse, Lies

“…Purpose Non-vitamin K antagonist oral anticoagulants (NOACs) are excreted by P-glycoprotein (P-gp) and some are metabolized by CYP450 enzymes such as CYP3A4…”
Get full text

Potentiometric Detection for Capillary Electrophoresis:  Determination of Organic Acids by De Backer, B. L, Nagels, L. J

“…A potentiometric detector was developed for CE and applied to the determination of aliphatic carboxylic acids (up to C10). The electrodes used were of the…”
Get full text

Interacting effects of warming and drought on regeneration and early growth of Acer pseudoplatanus and A. platanoides by Carón, M. M., De Frenne, P., Brunet, J., Chabrerie, O., Cousins, S. A. O., De Backer, L., Decocq, G., Diekmann, M., Heinken, T., Kolb, A., Naaf, T., Plue, J., Selvi, F., Strimbeck, G. R., Wulf, M., Verheyen, K.

“…Climate change is acting on several aspects of plant life cycles, including the sexual reproductive stage, which is considered amongst the most sensitive…”
Get full text

Relationship between arterial elasticity indices and carotid artery intima-media thickness by Duprez, Daniel A, De Buyzere, Marc L, De Backer, Tine L, Van De Veire, Nico, Clement, Denis L, Cohn, Jay N

“…Functional and structural changes of the arterial wall appear to serve as early hallmarks of the hypertensive disease process. Structural vascular changes can…”
Get full text

Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort study by Grymonprez, Maxim, Petrovic, Mirko, De Backer, Tine L, Ikram, M Arfan, Steurbaut, Stephane, Lahousse, Lies

“…Abstract Background Atrial fibrillation (AF) is associated with cognitive decline, with anticoagulated subjects potentially having a reduced risk compared with…”
Get full text

Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort study by Grymonprez, Maxim, De Backer, Tine L., Capiau, Andreas, Vauterin, Delphine, Mehuys, Els, Boussery, Koen, Steurbaut, Stephane, Lahousse, Lies

“…Aim Non‐vitamin K antagonist oral anticoagulants (NOACs) are increasingly preferred over vitamin K antagonists (VKAs) in atrial fibrillation (AF) management…”
Get full text

Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future by Geukens, T., Brandão, M., Laenen, A., Collignon, J., Van Marcke, C., Louviaux, I., Demey, W., Van Wambeke, S., Schrijvers, D., Lecomte, S., Mebis, J., Rutten, A., Fontaine, C., Lybaert, W., Aspeslagh, S., Goeminne, J.-C., Van Den Bulck, H., Seront, E., De Backer, L., De Roock, W., Ignatiadis, M., Prenen, H., Van Beckhoven, D., Heijlen, M., Verheezen, J., Rottey, S., Punie, K., de Azambuja, E.

“…Solid cancer is an independent prognostic factor for poor outcome with COVID-19. As guidelines for patient management in that setting depend on retrospective…”
Get full text

Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension by Duprez, Daniel A., Bauwens, Frank R., De Buyzere, Marc L., De Backer, Tine L., Kaufman, Jean M., Van Hoecke, José, Vermeulen, Alex, Clement, Denis L.

“…In a group of 36 untreated patients with mild-to-moderate essential hypertension (office systolic blood pressure [SBP] 160 ± 3.4 mm Hg, office diastolic blood…”
Get full text